Elevise Diabetes Care launches a global innovation competition to find digital solutions to help address the epidemic of type 2 diabetes.
Today, during the 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD), Eleviseia Diabetes Care announced the launch of the Eleviseia Diabetes Challenge, a global innovation contest that seeks innovative digital solutions to support the treatment of diabetes andImprove the lives of people living with type 2 diabetes.
The challenge aims to find new ways to help address the management of the World 2 Diabetes Epidemic discovering new innovative diabetes solutions.Finalists, runner -up and the winner will receive cash prizes to support more the development of their ideas from a total awards of 200,000 euros.
Through the challenge, Ascensia aims to support companies that are developing the next great jump in digital solutions that could facilitate a better treatment of type 2 diabetes and help relieve the load in people, health systemsand society.Although solutions and therapies in this area continue to improve year after year, many of the new emerging technologies currently in development need more investment to ensure that they can play a critical role in helping people with type 2 diabetes to better administer all aspects ofYour condition.
"In elevity we are very happy to launch this challenge, we want to encourage innovation in our field and rethink how digital technology can help people with type 2 diabetes to manage their lives day by day," said Michael Kloss, CEO of CEO ofElevise Diabetes Care."This challenge represents the modern approach to discover innovative solutions for people with diabetes, along with our own R&D. This challenge will not solve the diabetes epidemic alone, but it is a critical step in the development of newDiabetes solutions. Its objective is to find, support and foster ideas of recent companies that have the potential to revolutionize the treatment of diabetes.take them to a global population of patients. "
The contest will request shipments from Europe, America and Asia Pacific with open tickets on October 1, 2017 for Europe and November 6, 2017 for Asia Pacific and America.Tickets can be submitted through the online portal in elevative ascensioniabeteschallenge.com [ Link
A jury composed of independent diabetes and digital health experts from all over the world, as well as members of medical elevations, commercial and R&D teams, will evaluate the tickets and determine the finalists and the winner.Dr. William Polonsky, clinical psychologist, Dr. Masood Nazir, a general doctor with special interest in diabetes and digital health and Robin Swindell, a blogger with type 2 diabetes, have been confirmed as the first three judges, and additional judgesThey will be announced shortly.
Dr. William Polonsky, president and co -founder of the Behavioral Diabetes Institute, San Diego, USA, he explained, "behavioral interventions are the key to improving self -management in type 2 diabetes, and desperately digital solutions are needed as a means to involvelong -term patients and allow the change in sustainable behavior.From elevations diabetes challenge to treatto find the following innovations to address the load of type 2. "diabetes
Robin Swindell, a person with type 2 diabetes and an active blogger from the United Kingdom, said, "like most patients with type 2 diabetes, I only see a health professional for a couple of hours a year at most.For the rest of the time we have self -treatment.and handle our condition and provide motivation.
Elevise has been associated with YET2, an open innovation services company, to start this global challenge.YET2 will administer the initial shipping and review process.They will use their experience with open innovation challenges to facilitate entry review, manage the projection of intellectual property and support the evaluation process.
Michael Kloss added, "as a company that focuses on diabetes, we want to be promoting the diabetes innovation agenda, demonstrating our continuous support to the community of diabetes as a trusted partner and showing our commitment to continuing research, research,Innovation and development of new solutions. "
For more information about Eleviseia Diabetes Care, visit: Link more information about YET2, visit: Link
